Compare ELMD & EOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELMD | EOD |
|---|---|---|
| Founded | 1992 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.1M | 252.4M |
| IPO Year | 2010 | N/A |
| Metric | ELMD | EOD |
|---|---|---|
| Price | $29.46 | $6.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | 41.4K | ★ 118.1K |
| Earning Date | 02-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.28% |
| EPS Growth | ★ 30.89 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $66,218,999.00 | N/A |
| Revenue This Year | $14.63 | N/A |
| Revenue Next Year | $11.54 | N/A |
| P/E Ratio | $32.04 | ★ N/A |
| Revenue Growth | ★ 16.05 | N/A |
| 52 Week Low | $17.73 | $3.73 |
| 52 Week High | $35.41 | $4.71 |
| Indicator | ELMD | EOD |
|---|---|---|
| Relative Strength Index (RSI) | 59.08 | 55.70 |
| Support Level | $28.28 | $6.03 |
| Resistance Level | $30.73 | $6.12 |
| Average True Range (ATR) | 1.09 | 0.05 |
| MACD | 0.17 | 0.00 |
| Stochastic Oscillator | 73.80 | 58.02 |
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.